Intervacc AB (IVACC) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.094x

Based on the latest financial reports, Intervacc AB (IVACC) has a cash flow conversion efficiency ratio of -0.094x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr-29.33 Million ≈ $-3.16 Million USD) by net assets (Skr310.46 Million ≈ $33.41 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Intervacc AB defensive liquidity buffer to measure how many days the company can operate on defensive assets alone.

Intervacc AB - Cash Flow Conversion Efficiency Trend (2015–2024)

This chart illustrates how Intervacc AB's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Intervacc AB Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Intervacc AB ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Do Day Dream Public Company Limited BK:DDD	-0.001x
Moneyme Ltd AU:MME	0.340x
Victory Square Technologies Inc F:6F6	0.006x
B&B Triplewall Containers Limited NSE:BBTCL	0.198x
Analabs Resources Bhd KLSE:7083	-0.013x
Shree Rama Newsprint Limited NSE:RAMANEWS	0.111x
Lay Hong Bhd KLSE:9385	0.094x
Penguen Gida Sanayi AS IS:PENGD	0.009x

Annual Cash Flow Conversion Efficiency for Intervacc AB (2015–2024)

The table below shows the annual cash flow conversion efficiency of Intervacc AB from 2015 to 2024. For the full company profile with market capitalisation and key ratios, see Intervacc AB stock valuation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	Skr162.33 Million ≈ $17.47 Million	Skr-53.20 Million ≈ $-5.72 Million	-0.328x	-70.11%
2023-12-31	Skr237.93 Million ≈ $25.61 Million	Skr-45.83 Million ≈ $-4.93 Million	-0.193x	+30.95%
2022-12-31	Skr250.16 Million ≈ $26.92 Million	Skr-69.79 Million ≈ $-7.51 Million	-0.279x	-237.73%
2021-12-31	Skr308.25 Million ≈ $33.17 Million	Skr-25.46 Million ≈ $-2.74 Million	-0.083x	-38.88%
2020-12-31	Skr337.61 Million ≈ $36.33 Million	Skr-20.08 Million ≈ $-2.16 Million	-0.059x	-372.02%
2019-12-31	Skr219.82 Million ≈ $23.66 Million	Skr-2.77 Million ≈ $-298.10K	-0.013x	+40.50%
2018-12-31	Skr190.43 Million ≈ $20.49 Million	Skr-4.03 Million ≈ $-434.02K	-0.021x	+81.77%
2017-12-31	Skr164.90 Million ≈ $17.75 Million	Skr-19.16 Million ≈ $-2.06 Million	-0.116x	-260.12%
2016-12-31	Skr130.18 Million ≈ $14.01 Million	Skr-4.20 Million ≈ $-451.99K	-0.032x	+78.61%
2015-12-31	Skr126.52 Million ≈ $13.62 Million	Skr-19.09 Million ≈ $-2.05 Million	-0.151x	--

About Intervacc AB

ST:IVACC Sweden Biotechnology

Market Cap

$47.68 Million

Skr443.06 Million SEK

Market Cap Rank

#22148 Global

#417 in Sweden

Share Price

Skr1.30

Change (1 day)

-0.76%

52-Week Range

Skr0.61 - Skr1.39

All Time High

Skr89.40